ArticleThe Journal of clinical investigation2024

Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cells.

Sarah Hamze Sinno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.